Click here to book your

RT-PCR SARS-Cov-2 Test (Coronatest)

100 microbial species and resistance genes

in just 3 hours directly from whole blood

Sepsis is a life-threatening organ dysfunction caused by dysregulated host response to infection (Sepsis-3 definition). Between 27 and 30 million septic patients are recorded annually and between 6 to 9 million of these patients die (mortality rate ~ 30%). The cost of treating sepsis is enormous: in 2008 USD 14.6 billion was spent in the US alone (with an average growth rate in cost of 11.9%). Most types of microorganisms can cause sepsis. However, the vast majority of cases is caused by bacteria and fungi.

 

Experts strongly recommend focusing on the early identification of the sepsis-causing microorganisms to personalize and limit antimicrobial treatment to reduce life-threatening complications. If a patient receives appropriate antimicrobial therapy within the first hour of clinical diagnosis, chances of survival are close to 80%; this goes down by 7.6% for every hour of delay.

 

Cube Dx' early Pathogen Identification directly from whole blood and other sample matrices reduces time to result to 3 hours. Therefore targeted therapy can be chosen very quickly - even for patients already treated with antimicrobial agents.



Respiratorisches Virenscreening und Mutationsanalyse effizient vereint

Mit dem RT-PCR basierten Screening der wichtigsten respiratorischen Viren und der automatisierten Analyse von 20 Mutationen des SARS-Cov-2 Virus basierend auf compact sequencing hebt die Cube Dx die Mutationsanalytik auf ein neues Niveau. Durch die Breite der Analyse, die einfache Handhabung und automatisierte Auswertungen steigern Labors ihre Effizienz im Mutationsscreening deutlich und machen es möglich, bislang „ungesehene“ Mutationen im Auge zu behalten. 

mehr lesen

Cube Dx develops multiplexed screening for respiratory pathogens - including SARS-Cov-2

After the development of a highly sensitive RT-PCR test for the new coronavirus SARS-Cov-2, Cube Dx is now preparing for the upcoming challenges of the next cold season: a screening for respiratory viruses will enable physicians to rapidly stratify patients with respiratory symptoms.

mehr lesen